Drug Profile
Molgramostim topical gel - GeneScience
Alternative Names: Genfulin; GenLei; Topical hGM-CSF; Topical rhGM-CSFLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator GeneScience Pharmaceuticals
- Class Antibacterials; Antibronchitics; Antifibrotics; Antineoplastics; Chemoprotectants; Immunotherapies; Recombinant proteins
- Mechanism of Action Granulocyte macrophage colony stimulating factor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Burns; Wounds
Most Recent Events
- 03 May 2017 GeneScience Pharmaceuticals and Shanghai Ninth People 's Hospital plan a clinical trial for Wounds (Intrauterine adhesions) in China (ChiCTR-IPR-17011242)
- 13 Nov 2009 Molgramostim topical gel is still in preregistration for Wounds in China